PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 28: Articles 13501-14000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. The effects of long-term using once-a-month injectable contraceptive norethisterone enanthate / estradiol valerate on coagulation in the Chinese.
  2. Effects of low-dose oral contraceptives on blood lipids.
  3. Effects of oral contraceptive agents on serum fructosamine [letter]
  4. Effects of oral contraceptives on carbohydrate metabolism.
  5. The effects of oral contraceptives on well-being and sexuality.
  6. The effects of sex education on adolescent contraceptive behavior.
  7. Effects on state welfare, abortion and family planning policies on premarital childbearing among white adolescents.
  8. Efficacy of Veinobiase in venous disorders in combined estrogen-progestagen contraceptive users. Statistical study in 2295 patients. [Efficacite de Veinobiase sur les troubles veineux presentes par des femmes sous estroprogestatifs (etude statistique realisee chez 2 295 patientes)]
  9. Elevated serum cholesterol in otherwise healthy oral contraceptive users.
  10. Emergency Circular on family planning of 10 March 1990.
  11. Employment in family planning and women's status: the personal transformation of community workers.
  12. Endometrial and ovarian cancer and oral contraceptives.
  13. Endometrial cancer trends in England and Wales: a possible protective effect of oral contraception.
  14. Enterprise in Brazil: a strategic approach to private sector family planning.
  15. Enterprise in Mexico: a strategic approach to private sector family planning.
  16. Enterprise in Mexico: contraceptive marketing by mail.
  17. Enterprise in the Philippines: a strategic approach to private sector family planning.
  18. Enterprise in Zimbabwe: a strategic approach to private sector family planning.
  19. The Enterprise Program. Innovations in private sector family planning.
  20. An epidemiologic study of the relationship between psychosocial factors and contraceptive behavior in black adolescents.
  21. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.
  22. Epidemiological studies of oral contraceptive use and breast cancer. [Contraceptifs oraux et cancer du sein. Etudes epidemiologiques.]
  23. The epidemiology of oral contraceptives and breast cancer.
  24. Ethics, politics and contraception: Canada and the licensing of Depo-Provera.
  25. Evaluation of counseling skills training program for family planning nurses in Ogun State, Nigeria.
  26. Evaluation of salt consumption, physical activity, stress, tobacco and oral contraceptives in the epidemiology of essential hypertension. [Valoracion del consumo de sal, actividad fisica, estres, tabaco y anticonceptivos orales en la epidemiologia de la hipertension esencial.]
  27. Evaluation of the FPPS project (Family Planning Private Sector)
  28. An evaluation of the impact of the Population and Development Project, based on data from the 1984 Contraceptive Prevalence Survey.
  29. Evaluation of the Jamaica Population and Family Planning Services Project (Project No. 532-0069)
  30. Evaluation of the maternal, child health, and family planning in-service training programme.
  31. Evaluation of the Natural Family Planning Education and Training Project of the Family of the Americas Foundation.
  32. Evaluation of the Natural Family Planning Project, Project No. 936-3040.
  33. Evaluation team report for Family Planning Private Sector (FPPS Project)
  34. An evaluative study of the use of family planning services at the Board of Internal Trade (BIT) clinic, Dar-es-Salaam, Tanzania.
  35. The evolution and impact of policies on fertility and family planning: Brazil, Colombia, and Mexico.
  36. Examination of the rebound effect of biphasic oral contraceptives.
  37. Executive report: results of a cost-benefit study of family planning services delivery and utilization of maternal-child health services in the Peruvian Social Security Institute.
  38. Expanded services for intrauterine contraception.
  39. Expanding family planning services in rural Bangladesh through the Swanirvar community development program: final report.
  40. Extending the role of family planning [letter]
  41. Extending the role of family planning [letter]
  42. Factors affecting premarital sexual intercourse and contraceptive use among rural adolescent females.
  43. Factors affecting use of natural family planning in Utah.
  44. Factors differentiating effective use of contraception among adolescents.
  45. Factors which influence adolescents to engage in sexual activity without adequate contraception.
  46. The family and contraception.
  47. Family development: a functional choice-making approach based on the National Family Planning Program]
  48. Family development: a functional choice-making approach based on the national family planning program. Summary.
  49. Family health and family planning: the Chilean experience, 1965-1988. [Salud de la familia y paternidad responsable: la experiencia de Chile 1965-1988.]
  50. Family life, family planning and communication. A qualitative study on perceptions of urban and rural women, men and youth on family life and family planning issues. Summary report.
  51. Family planning -- the situation in Europe. [Planovane rodicovstvi -- situace v Evrope.]
  52. Family planning among low-income women in Rio de Janeiro: 1984-1985.
  53. Family planning and diverse declarations of human rights. [Planification familiale et diverses declarations des droits de la personne humaine.]
  54. Family planning and fertility transition in Shifang County, Sichuan, People's Republic of China.
  55. Family planning and maternal and child health in the World Bank's Population, Health and Nutrition Program.
  56. Family planning and maternal health care in Egypt.
  57. Family planning and reproductive behavior in Islamic countries in the Mediterranean area. [Pianificazione familiare e comportamenti riproduttivi nei paesi Islamici dell'area Mediterranea.]
  58. Family planning and the health of mothers and children.
  59. Family Planning Circular of 1990]
  60. The family planning clinic in Africa. A practical guide for contraception clinic professionals. Second edition.
  61. Family planning counseling and voluntary sterilization. A guide for managers.
  62. Family planning demand: a supply-demand analysis of changes in the demand for family planning in Indonesia from 1976 to 1987.
  63. Family planning dialogue. Rumors of contraception: myths vs facts.
  64. Family planning education and communication on T.V.
  65. Family planning evaluating service.
  66. Family planning for life: experiences and challenges for the 1990s, papers presented at the Conference on Management of Family Planning Programmes, Harare, Zimbabwe 1-7 October 1989.
  67. Family planning for seasonal migrant workers in Adana Province, Turkey.
  68. Family planning for the mentally disordered and retarded.
  69. Family planning for travellers.
  70. Family planning guidelines for midwives and nurses in rural areas. [Mwongozo wa wakunga na wauguzi vijijini kuhusu uzazi wa mpango.]
  71. Family planning in developing countries: accomplishments and challenges.
  72. Family planning in Eastern Europe and the Soviet Union: are things changing?
  73. Family planning in Fiji.
  74. Family planning in India (an economic assessment)
  75. Family planning in Indonesia: a successful community development programme.
  76. Family planning in rural Africa: can it work?
  77. Family planning in Siaya district, western Kenya: an analysis of factors influencing fertility levels.
  78. Family planning in Taiwan: the conflict between ideologues and technocrats.
  79. Family planning in the Northeast. [O planejamento familiar e o Nordeste.]
  80. Family planning in the USSR. Sky-high abortion rates reflect dire lack of choice.
  81. Family planning is crucial to child survival [editorial]
  82. Family planning logos. [Emblemes de planification familiale. Logotipos de planificacion familiar.]
  83. Family Planning Management Training. Evaluation of FPMT work with CEMOPLAF to increase their sustainability, Quito, Ecuador, August 6-10, 1990.
  84. Family planning needs and costs: Nepal, 1985-2000.
  85. Family planning needs of female chronic psychiatric outpatients. Dr. Coverdale and Dr. Aruffo reply [letter]
  86. Family planning outreach in Mirebalais, Haiti, final report.
  87. Family planning pilot projects.
  88. Family planning policy and socioeconomic factors affecting fertility in China.
  89. Family planning program evaluation in low prevalence countries: what works and why.
  90. The family planning program in Rwanda: assessment of ten years (1981-1991) and prospects. [Programme de planification familiale au Rwanda: bilan de dix ans (1981-1991) et perspectives.]
  91. Family planning program, Ogun State. Fact finding mission.
  92. Family planning programme of India - need for its reorientation.
  93. Family planning programmes: inheritance of the 1980s, challenges of the 1990s.
  94. Family planning programs in Botswana, Kenya and Zimbabwe.
  95. Family planning programs in the Third World.
  96. Family planning provision: whose needs are being met?
  97. Family planning services [letter]
  98. Family planning services delivery: Danish experience.
  99. Family planning services for psychiatric patients [letter]
  100. Family Planning Strategy Seminar, Guatemala City, Guatemala.
  101. Family planning through private practitioners: characteristics of Kenyan contraceptive acceptors.
  102. Family planning, health and human rights. 2nd Latin American Family Planning Congress. 1st Brazilian Family Planning Congress, Hotel Gloria, Rio de Janeiro, Brazil, August 20-24, 1989. Proceedings. [Planejamento familiar, saude e direitos humanos. II Congreso Latinoamericano de Planificacion Familiar. I Congresso Brasileiro de Planejamento Familiar, Hotel Gloria, Rio de Janeiro, Brasil, 20-24 de agosto de 1989. Memoria.]
  103. Family planning.
  104. Family planning: a human right for women.
  105. Family planning: clinical aspects.
  106. Family planning: everyone's concern.
  107. Family planning: from psychology to sociology. [Planificacion familiar: de la psicologia a la sociologia.]
  108. Family planning: opening the debate. [Planificacion familiar: se abre el debate.]
  109. Family planning: saving children, improving lives.
  110. Family planning: what role for African female communicators? [Planification familiale. Quel role pour les communicatrices africaines?]
  111. Favorable effects and unwanted side effects of hormonal contraceptives. [Gunstige Effekte und unerwunschte Nebenwirkungen hormonaler Kontrazeptiva.]
  112. Femshield acceptibility study among family planning acceptors (a pilot study)
  113. Fertility after contraception or abortion.
  114. Fertility and adoption of family planning among the Muslims of 24 Parganas, West Bengal. Part-II.
  115. The fertility and contraception book.
  116. Fertility and contraception in the rural areas. Important changes in contraception. [Fecundidad y anticoncepcion en el campo. Cambios importantes en anticoncepcion.]
  117. Fertility and family planning in the South Pacific.
  118. Fertility awareness in the 1990's: the Billings Ovulation Method of natural family planning. Scientific basis, practical application and effectiveness.
  119. Fertility survey, 1988: cohabitation, marriage, birth control, employment, and childbearing. [Onderzoek gezinsvorming 1988: samenwonen, trouwen, geboortenregeling, werken en kinderen krijgen.]
  120. Few women in Burkina Faso use contraceptives, but many know of and would consider using them.
  121. Final report of the operations research project on Integration of Maternal and Child Health, Family Planning and Nutrition Services in the City of Ouagadougou. [Rapport final du projet de recherche operationnelle sur l'Integration des Services SMI/PF/NUT dans la Ville de Ouagadougou.]
  122. Final report, operations research project: family planning and primary health care by traditional birth attendants.
  123. Final report, operations research project: Ghana Registered Midwives Association Family Planning Programme.
  124. Final report. Nigeria projects AF-NGA-04 and AF-NGA-25: Female Voluntary Surgical Contraception Booklets.
  125. Final report. Using television to influence family planning behavior: the experience in urban Nigeria with "In a Lighter Mood", Nigeria Project AF-NGA-07/08.
  126. Final report: "Can Family Planning Programs Serve the Reproductive Health Needs of Special Groups of High Risk Women?", Instituto de Medicina Tropical "Daniel A. Carrion", Universidad Nacional Mayor de San Marcos. Contract No. CI87.80A, December 1, 1987 - November 30, 1989.
  127. Final report: "Immediate Post-Partum and Post-Abortion Family Planning Program", PROFAMILIA (Promocion de Labores Educativas y Asistenciales en Favor de la Salud), IPSS (Instituto Peruano de Seguridad Social). Contract No. CI87.75A/CI88.19A and CI89.51A, November 15, 1987 - April 30, 1990.
  128. Final report: "Increasing Male Use of Contraceptives", Ministry of Health, St. Kitts-Nevis. Contract No. CI87.79A, December 15, 1987 - June 14, 1989.
  129. Final report: "Strategies for Increasing Contraceptive Use in Factories in Barbados", BFPA (Barbados Family Planning Association). Contract No. CI87.53A, October 1, 1987 - September 13, 1989.
  130. Final report: "Strategies to Promote Contraceptive Use among Women in High Risk Groups", GPPA (Grenada Planned Parenthood Federation). Contract No. CI87.44A, September 1, 1987 - August 31, 1989.
  131. Final report: "Testing Counseling Options for Provider-Dependent Contraceptive Methods", PROFAMILIA (Asociacion Dominicana Pro-Bienestar de la Familia, Inc.) Contract No. CI88.03A, January 1, 1988 - August 31, 1989.
  132. Final report: "The Impact of Incorporating Educational Strategies for AIDS Prevention and Control into Family Planning Programs", MEXFAM (Fundacion Mexicana para la Planeacion Familiar, A.C.), Contract No. CI88.27A, May 1, 1988 - July 15, 1989.
  133. Final report: Population Communication Services, Johns Hopkins University Project LA-HON-03, ASHONPLAFA. Radio and print materials campaign for a community-based contraceptive distribution program.
  134. Final report: Population Communication Services, the Johns Hopkins University, Project LA-BRA-02, ABEPF. AIDS Manual for Family Planning Workers.
  135. Final report: Replication and Distribution of Contraceptive Methods Print Materials, Nigeria Project AF-NGA-09.
  136. Final report: Zaire Family Planning Operations Research Project. Cooperative Agreement DPE-3030-A-00-4051-00.
  137. Final technical report. "Increasing Male Participation in Family Planning: a Test of Three Strategies". Contract CI87.38A, Federacion Mexicana de Asociaciones Privadas de Planificacion Familiar (FEMAP), September 1, 1987 - May 31, 1989.
  138. Financial sustainability of family planning programmes.
  139. First family planning visit in school-based clinics.
  140. First things first. A planned parenthood initiative to reduce adolescent childbearing by 50 percent by 1999.
  141. A focus group study of contraceptive drop-outs in Lesotho.
  142. Focus: family planning saves lives.
  143. Foreign assistance. Circumstances surrounding a family planning project.
  144. Formal operational thinking: the role of cognitive-developmental processes in adolescent decision-making about pregnancy and contraception.
  145. Forms of hormonal contraception. [Formen der hormonalen Kontrazeption.]
  146. Framework for analysing management challenges of family planning programmes.
  147. Frequency of use, knowledge, and attitudes toward the contraceptive sponge among inner-city black and Hispanic adolescent females.
  148. From buzzword to research priority: adding empowerment to the health, family planning and development research agendas.
  149. Future methods in contraceptive research.
  150. Future of intrauterine contraception (IUDS) [Avenir de la contraception endo-uterine.]
  151. The future of women's health -- the family planning clinic.
  152. Gastrointestinal disease and oral contraception.
  153. Gender effects in couples' sexual decision making and contraceptive use.
  154. Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
  155. Ghana family planning and health policy, legal, regulatory, institutional and economic issues and opportunities. [Summary report and final draft]
  156. Gingival reactions to oral contraceptives in a female population in the Dakar region. [Reactions gingivales aux contraceptifs oraux au sein d'une population feminine de la region de Dakar.]
  157. A global glimpse at the development and future of family planning research.
  158. Growing proportion of Thai women now begin contraceptive use to delay first marital birth.
  159. Guide for natural family planning trainers.
  160. A guide to interpreting contraceptive efficacy studies.
  161. Guidelines and checklists for program development in primary health care and family planning.
  162. Guidelines for breastfeeding in family planning and child survival programs.
  163. Haemorheological changes associated with the menstrual cycle and oral contraceptive therapy.
  164. Haitian fertility rate may have risen in 1980s; contraceptive use levels remain very low.
  165. Harbin municipal government experiment on family planning management information system.
  166. Health care policy and the Reagan administration: the case of family planning.
  167. Health education in sexuality and family planning: an experience. [Educacion para la salud en sexualidad y planificacion familiar. Una experiencia.]
  168. Health, education and family planning in the Philippines: governmental initiatives and household choice.
  169. Helping adolescents make the right contraceptive choice.
  170. Hemoglobin, serum iron and saturation of transferrin among users of intrauterine devices or oral contraceptives. [Hemoglobina, hierro serico y saturacion de transferrina en usuarias de dispositivos intrauterinos y anticonceptivos orales.]
  171. The hemolytic-uremic syndrome during use of Rigevidon as a contraceptive. [Khemolitichno-uremichen sindrom po vreme na kontratseptivna profilaktika s Rigevidon.]
  172. Henan Provincial Rules and Regulations on Family Planning.
  173. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
  174. Hereditary angioedema and oral contraception [letter]
  175. Heterosexual transmission of AIDS: proceedings of the Second Contraceptive Research and Development (CONRAD) Program International Workshop, held in Norfolk, Virginia, February 1-3, 1989.
  176. High risk pregnancies and family planning. [Grossesses a haut risque et planning familial.]
  177. Histological and microbiological findings of endometrium caused by the use of intrauterine device (IUD) as a method of contraception.
  178. A history of contraception: from antiquity to the present day.
  179. A history of men's and women's involvement in family planning in Bangladesh: an analysis of three surveys of couples, 1983, 1985/6 and 1989.
  180. The history of oral hormonal contraception. [De wordingsgeschiedenis van de anti-conceptiepil.]
  181. HIV and contraception: research priorities.
  182. Homonymous hemianopsia secondary to oral contraceptives. [Emianopsia omonima secondaria all'uso di estroprogestinici orali.]
  183. Hormonal contraception and estrogen replacement in postmenopausal women after treatment of malignant tumors. [Hormonale Kontrazeption und Estrogensubstitution in der Postmenopause im Zusammenhang mit malignen Tumoren.]
  184. Hormonal contraception and IUD: the little nuisances. [Contraception hormonale et sterilet: les "petits ennuis".]
  185. Hormonal contraception and levels of selected serum proteins. [Hormonalni antikoncepce a hladina vybranych serovych bilkovin.]
  186. Hormonal contraception and the risk of cancer. [Hormonale Kontrazeption und Krebsrisiko.]
  187. Hormonal contraception in adolescents and in the pre-menopause. [Hormonale Kontrazeption bei Jugendlichen und in der Pramenopause.]
  188. Hormonal contraception in developing countries.
  189. Hormonal contraception using estroprogestins. [La contraccezione ormonale mediante estroprogestinici.]
  190. Hormonal contraception with LHRH agonists and the prevention of breast and ovarian cancer.
  191. Hormonal contraception.

     

  192. Hormonal contraception.
  193. Hormonal influence on calcitonin gene-related peptide in man: effects of sex difference and contraceptive pills.
  194. How couples choose birth control.
  195. How Thailand's family planning program reached replacement level fertility: lessons learned.
  196. How to give priority to family planning in PHC programmes.
  197. Human insulin and C-peptide responses to an oral glucose load during the luteal phase, in anovulatory cycles or amenorrhoea, under oral contraceptive treatment and after ovariectomy.
  198. Hypertension, oral contraceptive use, and smoking among young and middle-aged American women.
  199. Hypothesis. Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?
  200. The Ibadan market-based distribution project: partnership for primary health care and family planning.
  201. Ibadan market-based health and family planning project, final report.
  202. Identifying and reducing barriers to utilization of family planning services for women in drug treatment programs.
  203. An illustrated history of contraception: a concise account of the quest for fertility control.
  204. Illustrated print materials for health and family planning education.
  205. The immunobiology of follicle-stimulating hormone and inhibin: prospects for a contraceptive vaccine.
  206. Immunoglobulin levels in serum and uterine fluids in women using intrauterine contraceptive device.
  207. Immunological status of women with prolonged oral contraceptives and occurrence of giardiasis.
  208. The impact of AIDS on knowledge and attitudes about condoms for family planning in urban Mexico.
  209. Impact of integration of family planning with MCH and other development programmes.
  210. The impact of radio on family planning attitudes and practice in Nigeria: the experience in Anambra State.
  211. Improving skill and knowledge of midwives practitioners to facilitate better quality services in MCH and family planning by Midwives Association.
  212. Improving the utilization and self-sufficiency of private urban family planning clinics in Indonesia. Final report.
  213. Incentive and compensation for family planning in South Asia: a brief note.
  214. Incentives and their influence on appointment compliance in a teenage family-planning clinic.
  215. Incorporating AIDS prevention activities into a family planning organization in Colombia.
  216. Increased heparin cofactor II levels in women taking oral contraceptives.
  217. Increased interest in natural family planning. [Okat intresse for naturlig familjeplanering.]
  218. Increasing the application of operations research findings in public sector family planning programs: lessons from the ICDDR,B Extension Project.
  219. Increasing the participation of private nurse-midwives in the delivery of longer-acting family planning methods in Lampung, Indonesia. Final report.
  220. India's high fertility despite family planning: an appraisal.
  221. Indirect health interventions with reference to family planning and breastfeeding.
  222. Individual differences in attitude-behavior consistency: the prediction of contraceptive behavior.
  223. Indonesia: family planning perspectives in the 1990s.
  224. Indonesia: family planning perspectives in the 1990s.
  225. Indonesian family planning data sheet. [Lembaran data keluarga berencana nasional.]
  226. Inefficacy of oral contraception during use of minocycline. [Ineffectiviteit van orale anticonceptie tijdens gebruik van minocycline.]
  227. Inefficacy of oral contraceptives during administration of minocycline (letter) [Ineffectiviteit van orale anticonceptie tijdens gebruik van minocycline.]
  228. Inefficacy of oral contraceptives during administration of minocycline (letter) [Ineffectiviteit van orale anticonceptie tijdens gebruik van minocycline.]
  229. Infant mortality, fertility and family planning: an analysis of relationships.
  230. The influence of a community-based distribution programme on contraceptive choice.
  231. The influence of a unified IEC strategy on family planning acceptance and use among married couples of reproductive age in Cebu City. The research component of "Pamilya - Cebu" Project.
  232. Influence of oral contraception on the occurrence of rheumatoid arthritis in female sibs.
  233. Influence of oral contraceptives and calcium supplements on zinc status.
  234. Influence of oral contraceptives on drug therapy.
  235. Informing and educating clients about family planning: prototypes. Draft. Partial manuscript. Vasectomy: client information. Preoperative and postoperative instructions about vasectomy.
  236. Initial selection of oral contraceptives.
  237. The injectable contraceptive as revealer of social inequalities on the basis of the results of a socio-epidemiologic survey. [Le contraceptif injectable comme revelateur d'inegalites sociales a partir des resultats d'une enquete socio-epidemiologique.]
  238. Injectable contraceptives and risk of invasive cervical cancer: evidence of an association.
  239. The injectable contraceptives: present and future trends.
  240. Injectable contraceptives: their role in family planning care.
  241. Innovations from the Integrated Family Planning and Parasite Control Project: PDA experience.
  242. Innovators and imitators in the practice of contraception in town and country.
  243. Institute for International Studies in Natural Family Planning: a university-based organization's role in breastfeeding policy.
  244. Integrated family planning service in an urban maternity hospital at Be, Lome.
  245. Integrated Family Planning, Nutrition, and Parasite-Control Project in Ghana: a baseline survey report.
  246. Integrating family planning and MCH services in urban health centers in Burkina Faso.
  247. Integration of family planning into maternal and child health and other services at Harare Central Hospital.
  248. Integration of family planning services in health programmes in Jamaica and Trinidad.
  249. The integration of IEC into family planning programs: lessons applicable to operations research.
  250. Interaction between antibiotic therapy and contraceptive drugs. [Interazione tra terapia antibiotica e farmaci anticoncezionali.]
  251. Interaction between certain psychopharmaca and low-dose oral contraceptives.
  252. Interaction of griseofulvin and oral contraceptives.
  253. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
  254. Interactions between the oral contraceptive pill and antibiotics [letter]
  255. Interactions with oral contraceptives.
  256. The international family planning movement.
  257. The international family planning movement.
  258. International introduction of a new contraceptive: the Copper T380A intrauterine device.
  259. Intrauterine contraceptive devices can be left in longer.
  260. Intrauterine contraceptive devices.
  261. Intrauterine contraceptive devices: comparing health centre and district hospital costs in Thailand.
  262. Introduction of new contraceptives into family planning programmes. Guidelines for social science research.
  263. An investigation of contraception with the diaphragm method.
  264. Investing in the future: a report on the cost of family planning in the year 2000.
  265. Iron status: effects of oral contraceptives and calcium supplements for women and diets emphasizing fish for men.
  266. Is development really the best contraceptive? A 20-year trial in Comilla district, Bangladesh.
  267. Is family planning effective and profitable in Rwanda? [La PF est-elle efficace et rentable au Rwanda?]
  268. Issues in family planning clinic management in seven Latin American countries.
  269. Jejuno-sigmoid fistula caused by intrauterine contraceptive device. Case report and suggested mechanism of fistula formation.
  270. The Jephcott Lecture, 1989. An overview of the benefits and risks of combined oral contraceptives.
  271. K.A.P. study of family planning among married Orang Asli women of Kuala Langat district, Selangor Darul Ehsan, Malaysia.
  272. The Kenya Family Planning IE&C Survey.
  273. Knowledge and use of postcoital contraception: a survey among health professionals in Tower Hamlets.
  274. Knowledge and use of the contraceptive effect of breast-feeding: evidence from Malaysia and Guatemala.
  275. Lactation and contraception.
  276. Lagos State family planning / IEC campaign report of [focus group discussions] FGD. (Lagos State R&E)
  277. Levels and trends of contraceptive use in developing countries with special references to Africa.
  278. The link between abortion and contraceptive use in Kenya.
  279. Lipid metabolism and hormonal contraception. [Fettstoffwechsel und hormonale Kontrazeptiva.]
  280. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
  281. Long-acting contraceptive agents: testosterone esters of unsaturated acids.
  282. Long-acting hormonal contraception. [Anticoncepcion hormonal de accion prolongada.]
  283. Long-acting methods of contraception.
  284. Long-acting progestin contraceptives.
  285. Long-term experience with a low-dose oral contraceptive.
  286. Long-term health risks and benefits of oral contraceptive use.
  287. Long-term use of copper intrauterine devices. A statement from the Medical Advisory Committee of the Family Planning Association and the National Association of Family Planning Doctors.
  288. Mainstreaming of natural methods of family planning in selected family planning agencies that receive Title X funding.
  289. Male attitudes towards family planning in Accra, Ghana.
  290. Male attitudes towards family planning: an assessment of potential demand for vasectomy in Honduras.
  291. Male involvement in family planning in Rwanda.
  292. Male involvement programs in family planning: lessons learned and implications for AIDS prevention.
  293. Male participation in family planning and its demographic impact.
  294. Males' use of public health department family planning services.
  295. Management information system for family planning, its linkages with maternal and child health programmes: an NGO's perspective.
  296. Managing family planning in Sri Lanka: achievements and challenges.
  297. Maternal and child health / family planning: 1990 national report.
  298. Maternal and child health / family planning: 1990 national report.
  299. Measuring the impact of family planning programs.
  300. The mechanism of intrahepatic cholestasis induced by oral contraceptives. [Oral kontraseptiflerin neden oldugu intrahepatik kolestazis'in mekanizmasi.]
  301. Medical service standards for clinical contraceptions and VSC in Nepal.
  302. Medical termination of pregnancy and concurrent contraceptive acceptance.
  303. Megestron: long-acting, injectable contraception.
  304. Megestron: long-acting, injectable contraceptive. Guidelines for the health worker.
  305. Melatonin contraceptive readied.
  306. Men's absence in family planning clinics.
  307. Menstrual beliefs and knowledge and contraceptive effectiveness in a military population.
  308. Metabolic aspects of oral contraceptives of relevance for cardiovascular disease.
  309. Metabolism of the contraceptive steroid desogestrel by human liver in vitro.
  310. The methodology of calculating couple years of protection: a case for the Zimbabwe National Family Planning Council.
  311. Midwives and family planning in Zimbabwe.
  312. Model of training, supervision and quality control in community-based family planning programs. [Modelo de capacitacion, supervision y control de calidad en programas comunitarios de planificacion familiar.]
  313. A model to detect interactions between roxithromycin and oral contraceptives.
  314. Modern oral contraceptives and dysmenorrhoea.
  315. Modern trends in contraception.
  316. Monitoring and evaluating family planning programmes in the 1990s.
  317. Monthly injectable contraceptives and breast cancer.
  318. More thorough training needed for grass-roots family planning workers.
  319. The "morning after pill" is the wrong name for it. Women's knowledge of postcoital contraception in Tower Hamlets.
  320. Morocco. Visites a Domiciles de Motivation Systematique (VDMS). Household Distribution of Family Planning. Report of a document review of the implementation and achievements of an operations research project.
  321. Mortality among oral contraceptive users [letter]
  322. Mortality among oral contraceptive users [letter]
  323. Mortality among oral contraceptive users [reply]
  324. Mortality among oral contraceptives users [letter]
  325. Motivation gap in contraceptive use in Egypt.
  326. A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 mg) plus E2 valerate (5 mg) given every month and NET-OEN (200 mg) given every 2 months as intramuscular injection -- a report of 12-month study.
  327. A multilevel analysis of adolescent contraceptive use at first nonmarital intercourse.
  328. The multiple health benefits of oral contraceptives.
  329. A multivariate analysis of factors related to adolescent sexuality and contraceptive use.
  330. My university. What I learned from the Productive Cooperative Movement to Promotion of Humanistic Family Planning.
  331. Mycoplasmas among clients attending a family planning clinic in Zaria, Nigeria.
  332. A mystery shopper study: evaluation of the retailer training component of the Ghana Contraceptive Social Marketing Program.
  333. National Contraception Survey, 1990. Preliminary report. [Enquete Nationale sur la Contraception 1990. Rapport preliminaire.]
  334. The national family planning IEC campaign of Turkey.
  335. National Indonesia Contraceptive Prevalence Survey, 1987, summary report.
  336. Natural family planning in today's world.
  337. Natural family planning. [Naturliche familienplanung.]
  338. The need for future studies of breast cancer risk in relation to oral contraceptive use: a comprehensive strategy.
  339. Neonatal choreoathetosis following prenatal exposure to oral contraceptives [letter]
  340. New developments in contraceptive technology.
  341. New directions in family planning communication: 12 predictions for the 1990s.
  342. New IPPF statement on breast feeding, fertility and post-partum contraception.
  343. New IPPF statement on breastfeeding, fertility and post-partum contraception.
  344. The new power of labels in the abortion wars. The legislative fight over "birth control".
  345. New rules for family planning and land management in Shaanxi province.
  346. A new terminal judgment method for family planning: indistinct comprehensive judgment.
  347. The next generation of oral contraceptives in clinical practice. Chairman's summary.
  348. Nigeria's contraceptive market-traders.
  349. Nonsystemic contraception. [La contraception locale.]
  350. Normalization of menstrual pattern after liver transplantation: consequences for contraception.
  351. Norplant contraceptive implants -- a comparison of capsules versus rods in Singapore.
  352. Norplant contraceptive implants: opinion of Dominican women who used this method. [Implantes anticonceptivos Norplant: opinion de mujeres dominicanas que usaron el metodo.]
  353. Norplant contraceptive method gains ground. Approved for distribution in the United States. [La methode contraceptive Norplant gagne du terrain. Approuvee pour distribution aux Etats Unis.]
  354. Norplant contraceptive subdermal implants: managerial and technical guidelines.
  355. Norplant contraceptive subdermal implants: manual for clinicians.
  356. Note on unmet need for family planning in Kenya.
  357. Nurse practitioner intervention to improve postpartum appointment keeping in an outpatient family planning clinic.
  358. Objectives and strategies of the national family planning program. [Objectifs et strategies du programme national de planification familiale.]
  359. Obstetrical history and use of contraceptive methods by women in an urban health area. [Historia obstetrica y uso de metodos contraceptivos de las mujeres de un area de salud urbana.]
  360. Obstetrics and Gynecology Grand Rounds Clinical Case Management XVIII: Oral contraceptive pills. Part I: Formulations, selection and common side effects.
  361. Obtaining a change in attitude toward family planning. [Lograr un cambio de actitud con respecto a la planificacion familiar.]
  362. On the relationship between fertility attitudes and contraceptive behaviour: the case of Lesotho.
  363. Operational policies for effective voluntary sterilization services in family planning programs. Draft.
  364. Opportunities for improving the quality of care in family planning services through introduction of new contraceptive methods.
  365. Opposition as a challenge to family planning programmes in Zambia.
  366. Optimal birth control of population dynamics. II. Problems with free final time, phase constraints, and mini-max costs.
  367. Options for delivering health and family planning services in India through managed health care insurance.
  368. Oral contraception and breast cancer in New Zealand.
  369. Oral contraception and systemic lupus erythematosus (SLE) [Contraception hormonale et lupus.]
  370. Oral contraception for women in their 40s. Conclusions.
  371. Oral contraception. [Contraception orale.]
  372. Oral contraceptive agents and antithrombin III. [Oralni antikontseptivni sredstva i antitrombin III.]
  373. Oral contraceptive pills. Part II: Potential complications and health benefits.
  374. Oral contraceptive therapy and the surgical management of ENT patients: a review of current clinical practice.
  375. Oral contraceptive use and breast cancer risk in young women: subgroup analyses.
  376. Oral contraceptive use and functional ovarian cysts.
  377. Oral contraceptive use in relation to the risk of breast cancer: the data of the Slone Epidemiology Unit in women aged 45-59 years.
  378. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix.
  379. Oral contraceptive use, other personal characteristics and breast cancer risk in San Francisco Bay Area women, 1970-77.
  380. Oral contraceptives and breast cancer [editorial]

     

  381. Oral contraceptives and breast cancer [editorial]
  382. Oral contraceptives and breast cancer risk -- a problem of consent.
  383. Oral contraceptives and breast cancer risk: a case-control study.
  384. Oral contraceptives and breast cancer.
  385. Oral contraceptives and breast cancer.
  386. Oral contraceptives and breast cancer: a case-control study with hospital and community controls [letter]
  387. Oral contraceptives and breast cancer: a consumer toxic tort.
  388. Oral contraceptives and breast cancer: the UK National Case-Control Study.
  389. Oral contraceptives and breast cancer: update of an Italian case-control study.
  390. Oral contraceptives and cardiovascular disease. [Doustne srodki antykoncepcyjne a choroby ukladu krazenia.]
  391. Oral contraceptives and cardiovascular risk. Taking a safe course of action.
  392. Oral contraceptives and diabetes mellitus [correction]
  393. Oral contraceptives and diabetes mellitus [letter]
  394. Oral contraceptives and hepatic effects. [Contraccettivi orali e danno epatico.]
  395. Oral contraceptives and HIV transmission.
  396. Oral contraceptives and human immunodeficiency virus infection [letter]
  397. Oral contraceptives and infection rates [letter]
  398. Oral contraceptives and infection rates. Reply [letter]
  399. Oral contraceptives and rheumatoid arthritis: new data from the Royal College of General Practitioners' oral contraception study.
  400. Oral contraceptives and risk of breast cancer.
  401. Oral contraceptives and risk of breast cancer.
  402. Oral contraceptives and serum lipids [letter]
  403. Oral contraceptives and serum lipids. Reply [letter]
  404. Oral contraceptives and the risk of breast cancer.
  405. Oral contraceptives in women with diabetes.
  406. Oral contraceptives today [editorial]
  407. Oral contraceptives, insulin resistance and ischemic vascular disease.
  408. Oral contraceptives.
  409. Oral histories help family planning evaluators.
  410. Order No. 28/MAS/PF of 5 October 1990 organizing and establishing the functions of the Directorate of Family Planning. [Arrete No. 28/MAS/PF du 5 octobre 1990, portant organisation et attributions de la Direction de la Planification familiale.]
  411. Order No. 50 of 30 January 1990 approving technical standards for the use of hormonal contraceptives and intrauterine devices. [Ordin pentru aprobarea Normelor tehnice privind utilizarea contraceptiei hormonale si prin dispozitive intrauterine.]
  412. Organizational legitimacy and the social construction of contraceptives: the politics of technological choice.
  413. Organizing a family planning floating clinic.
  414. Out from behind the contraceptive Iron Curtain.
  415. Ovarian cysts due to hormonal contraception. [Les kystes ovariens reactionnels de la contraception hormonale.]
  416. Overview of previous research conducted on the oral contraceptive market in Morocco.
  417. An overview of the A.I.D. Family Planning Operations Research Program.
  418. Pakistan. Contraceptive forecast for 1990 and 1991 and issues related to the distribution of contraceptives. Trip report, January 22 - February 1, 1990.
  419. Partial expulsion of Hamou intratubal contraceptive device (ITCD)
  420. Patterns of contraception in the United States: how important are religious factors.
  421. Paving the road to family planning communication in Cameroon. Focus group interview research results. [Paver le chemin a la communication pour la planification familiale au Cameroun. Resultats de la recherche basee sur les interviews de groupe dirigees.]
  422. Pelvic actinomycosis: beware the intrauterine contraceptive device.
  423. Perceived male support: a comparison of Chicago and Madison adolescents making initial visits to family planning clinics.
  424. Pharmacokinetic drug interactions with oral contraceptives.
  425. The Philippine Family Planning Program (1990-1994)
  426. The Philippine Family Planning Program (1990-1994)
  427. Physicians and injectable contraception. Analysis of reasons for prescribing as described in physicians' statements. [Medecins et contraception injectable. Analyse des logiques de prescription a partir des discours de medecins.]
  428. Planned Parenthood of Kansas, Inc. v. City of Wichita [3 January 1990. Excerpts]
  429. Planning family in India: prevedic times to early 1950s.
  430. Planning your family: a teaching aid for use in family planning education. [Jinsi ya kupanga uzazi wako: mwongozo kwa ajili ya kutoa elimu ya afya kuhusu uzazi wa mpango.]
  431. Platelet function studies in women on oral contraceptive pills.
  432. The politics of contraception in South Africa.
  433. The politics of family planning in Mexico: recent experience. [La politica de planificacion familiar en Mexico: una experiencia reciente.]
  434. The politics of family planning: sterilization and human rights in Bangladesh.
  435. Poor contraceptive use in the teenage years: situational and developmental interpretations.
  436. Populate and perish: Australian women's fight for birth control.
  437. Population and family planning education in Indonesia.
  438. Population control and family planning.
  439. Population policy and maternal child health / family planning programs: networking for better program design and evaluation.
  440. Population studies in Sri Lanka and Indonesia based on the 1987 Sri Lanka Demographic and Health Survey and the 1987 National Indonesia Contraceptive Prevalence Survey.
  441. Post-ovulatory contraception.
  442. Postcoital contraception.
  443. Postcoital contraception. [La contraception post-coitale.]
  444. Postpartum and postabortal contraception. [Contraception du post-partum et du post-abortum.]
  445. Postpartum contraception conference held.
  446. Postpartum contraception: developing strategies for expanded services.
  447. Postpartum contraceptive methods.
  448. Postpartum family planning in the 1990s.
  449. Postpartum family planning. What is it? Where does it come from? And what can it be?
  450. Potential demand for family planning assistance in the private sector in Kenya.
  451. Poverty and population: a study of reproductive ideals and attitude towards family planning among the rural poor in Uttar Pradesh.
  452. Poverty, population growth, and family planning in Latin America and the Caribbean.
  453. Practical observations of the use of the contraceptive preparation Anteovin. [Prakticheski nabliudeniia ot prilaganeto na antikontseptivniia preparat Anteovin.]
  454. Predicting contraceptive method usage among women in West Scotland.
  455. Pregnancy and liver tumors induced by oral contraceptives. [Durch orale Kontrazeptiva induzierte Lebertumoren und Schwangerschaft.]
  456. Pregnancy diagnosis and contraception.
  457. Pregnancy in African-American adolescents: health, education, economic and contraceptive factors.
  458. Pregnancy, birthing and family planning in Kenya: changing patterns of behaviour. A health service utilization study in Kisii District.
  459. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer.
  460. Premarital sexual activity and contraceptive use among young women and men in Santiago, Chile.
  461. Preparing for the twenty-first century: principles for family planning service delivery in the nineties.
  462. Prescribing oral contraceptives.
  463. Present status of contraceptive vaginal rings.
  464. Prevalence of cholelithiasis in relation to use of hormonal contraceptives. [Pravalenz der Cholelithiasis in Abhangigkeit von der Einnahme hormonaler Kontrazeptiva (HK)]
  465. Prevention of pregnancy by using intrauterine contraceptive devices. [Preduprezhdenie beremennosti s pomoshchiu vnutrimatochnykh kontratseptivov.]
  466. Private firm offers family planning.
  467. Private midwives: a new approach to family planning service delivery in Ghana.
  468. Private sector family planning in Jamshedpur, India: a cost-benefit case study.
  469. Private sector local production of contraceptives: current options for A.I.D.
  470. Producing family planning training films in Africa: involving the audience from A to Z.
  471. Profile of oral contraceptive and intrauterine device users at Benghazi.
  472. Programmatic issues and concerns surrounding postpartum contraception.
  473. Project summaries, September 15, 1984 - September 14, 1990. INOPAL I: final technical report, volume II. Operations Research in Family Planning and Maternal-Child Health Service Delivery Systems in Latin America and the Caribbean (U.S.A.I.D. Cont. DPE-3030-C-00-4074-00)
  474. The promotion of family planning by financial payments: the case of Bangladesh.
  475. Promotion of family planning services: experience of Ruhengeri. [La promotion des services de planification familiale. Experience de Ruhengeri.]
  476. Proposed project to support the contribution of local government units to the Philippine Family Planning Program.
  477. A prospective study of genital infections in a family-planning clinic. 1. Microbiological findings and their association with vaginal symptoms.
  478. A prospective study of genital infections in a family-planning clinic. 2. Chlamydia infection -- the identification of a high-risk group.
  479. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis.
  480. Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
  481. The psychology of contraceptive surprises: cumulative risk and contraceptive effectiveness.
  482. Public health and men's role in family planning. [Afya ya jamii na kupanga uzazi kwa wanaume.]
  483. Public health nurses and family planning.
  484. Purchase description for condoms, rubber contraceptive.
  485. Pyrimethamine: an approach to the development of a male contraceptive.
  486. A qualitative analysis of the contraceptive behavior patterns of adolescent women.
  487. Qualitative study of oral contraceptive use in Egypt: interviews with OC users and providers. Final report.
  488. Quality in family planning. A business management approach.
  489. Quality of care in commercial and social marketing family planning programs in Latin America and the Caribbean.
  490. Quality of care in family planning clinical services in Latin America. [Calidad de atencion en los servicios clinicos de planificacion familiar en America Latina.]
  491. Quality of care in the family planning program of Kenya.
  492. Quality of services and family planning in Gujarat State, India: an exploratory analysis.
  493. Rate of miscarriages in oral contraceptive users. [Frequence des fausse-couches chez les utilisatrices de la contraception orale.]
  494. Rationale for family planning and the background to Zambia's population policy.
  495. Readability of commercial and generic contraceptive instructions.
  496. Readings on teenage pregnancy from Family Planning Perspectives, 1985 through 1989.
  497. A reassessment of the concept of reproductive risk in maternity care and family planning services. Proceedings of a seminar presented under the Population Council's Robert H. Ebert Program on Critical Issues in Reproductive Health and Population, February 12-13, 1990, the Population Council, New York, New York.
  498. Reassessment of the metabolic effects of oral contraceptives.
  499. Recall study of family planning campaign in Swedru.
  500. Recently approved and experimental methods of contraception.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.